In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...

Article ‘Count’ and ‘Share’ for Research Center for Computer-aided Drug Discovery, SIAT CAS based on listed parameters only. The articles listed below published by authors from Research Center for ...

Computer-aided drug design (CADD) that combines computational chemistry, molecular modeling, and rational drug design with artificial intelligence (AI) and machine learning is rapidly changing the ...

Denmark unveiled an Nvidia-powered supercomputer that will be used by researchers from Novo Nordisk A/S and other Danish pharmaceutical companies as they seek novel drugs and smarter trial designs.

Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a “computer-aided design suite” for molecules.

How are we improving the way the field of drug discovery creates machine learning algorithms to predict a protein’s interactions with a small molecule? The drug development pipeline is a costly and ...

In what Lawrence Livermore National Lab said is “a substantial milestone for supercomputing-aided drug design,” LLNL and BridgeBio Oncology Therapeutics today announced clinical trials have begun for ...

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.

Chai Discovery, an OpenAI-supported biotech startup, has raised $130 million in a Series B round, reaching a valuation of $1.3 billion.

The artificial intelligence (AI) revolution seems to pick up pace from one week to the next, but what does it mean for the pharmaceutical sector? Since its inception, the pharmaceutical industry has ...